Treating Micro-Metastatic

Donate to PCRI: pcri.org/donate/
For more information, visit pcri.org
0:28 What is micrometastatic disease, and how is it relevant in prostate cancer treatment?
3:53 How has the advent of the PSMA PET scan affected treatment of micrometastatic disease?
7:17 Should every new prostate cancer patient be getting a PSMA PET scan?
9:58 What options are there for those who've already received treatment and are now monitoring?
12:18 How might a prostate cancer patient be monitored after treatment?
12:53 What "cured" mean in the context of prostate cancer?
13:45 What hormone therapy options are there for treating micrometastatic disease?
17:39 How should a patient go about communicating their treatment preferences to their doctor?
18:57 Have PSMA PET scans changed the definition of micrometastatic disease?
20:05 Alex's conclusions
21:00 If you need help
Don't know your stage? Take the quiz: visit www.prostatecan...
To learn more about prostate cancer, visit www.pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.